4Dr. Y. Yamasaki,R. Kawamori,H. Matsushima,H. Nishizawa,M. Kodama,M. Kubota,Y. Kajimoto,T. Kamada. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery[J] 1995,Diabetologia(5):585～591
二级参考文献12
1陈达光，中华心血管病杂志，1994年，22卷，83页
2陈达光，Chin J Hypertensi，1993年，1卷，11页
3Smith LR,Harrell FE.Determinants of raely versus late cardiac death in patients undergoing CABG suegrey.Circulation,1991,84:245
4Kiechl S,Willeit J.The natural course of atherosclerosis (Part I):incidence and progression.Arterioscler Thromb Vasc Biol,1999,19:1 484-490
6Salonen JT,Salonen R.Ultrasound B-mode imaging in observational studies of atherosclerosis progression.Circulation,1993,87:Ⅱ-56
7Chambless LE,Heiss G,Folsom AR.Association of coronary heart disease incident with cartoid arterial wall thickness and major risk factors:the Atherosclerosis Risk in Communties (ARIC) study.Am J Epidemiol,1997,146:483-494
8Falk E.Unstable angina with fatal outcome:dynamic coronary thrombosis leading to infarction and/or sudden death:autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation,1985,71:699-708
9Steinne W,Kloetzsch C.Carotid artery disease assessed by color flow imaging:correlation with standard sonography and angigraphy.J AJNR,1990,11:259-266
5Matsushima Y, Takase B, Uehata A, et al. Comparative predic- tive and diagnostic value of flow-mediated vasodilation in the bra- chial artery and intima media thickness of the carotid artery for as- sessment of coronary artery disease severity. IntJ Cardiol, 2007, 117(2) : 165-172.
6Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular dis- ease. Arterioscler Thromb Vasc Biol, 2005,25(6) : 1102-1111.
7Samsamshariat SZ, Basati G, Movahedian A, et al. Elevated plasma myeloperoxidase levels in relation to circulating inflamma- tory markers in coronary artery disease. Biomark Med, 2011, 5 (3) :377-385.
8Wainstein RV, Wainstein MV, Ribeiro JP, et al. Association be- tween myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease. Clin Biochem, 2010,43(1-2) : 57-62.
9Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxi- dase: Role in cardiovascular biology and disease. Circ Res, 2000, 86(5) : 494-501.
